Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma.
Blood
; 130(22): 2401-2409, 2017 11 30.
Article
in En
| MEDLINE
| ID: mdl-29018077
Full text:
1
Database:
MEDLINE
Main subject:
Sulfonamides
/
Bridged Bicyclo Compounds, Heterocyclic
/
Multiple Myeloma
/
Antineoplastic Agents
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2017
Type:
Article